Peer Review History
| Original SubmissionJuly 11, 2022 |
|---|
|
PONE-D-22-19515Survival of the fittest in the pandemic age: Introducing Disease-Related Social DarwinismPLOS ONE Dear Dr. Nachtwey, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. I was able to get one evolutionary psychologist and one prejudice researcher with EP leanings. Both identified major issues that they think warrant your attention prior to publication but they suggest there is "light at the end of the tunnel" for this paper. Please submit your revised manuscript by Nov 05 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Peter Karl Jonason Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. You indicated that ethical approval was not necessary for your study. Could you please provide further details on why your study is exempt from the need for approval and confirmation from your institutional review board or research ethics committee (e.g., in the form of a letter or email correspondence) that ethics review was not necessary for this study? Please include a copy of the correspondence as an ""Other"" file. 3. Thank you for stating the following financial disclosure: "The authors did not receive funding for this work." At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript entitled „Survival of the fittest in the pandemic age: Introducing Disease-Related Social Darwinism” describes two studies on the Disease-Related Social Darwinism (DRSD) as a new concept inspired by the changes in societal attitudes toward protective measures and politics during the COVID-19 pandemic. The Authors described this construct (DRSD) in the context of sociopolitical attitudes (SDO; RWA; SD) and examined the expectations regarding political preferences related to this belief (DRSD). Since this new construct seems to be interesting development of social Darwinism, I have some suggestions concerning the description of the studies and its methodology. #1. The Authors tested a lot of hypotheses concerning various groups of variables possibly corelated with DRSD. I think that the introduction would benefit from dividing it into sections concerning the associations between groups of such variables and DRSD (e.g., Political preferences and DRSD; DRSD and the COVID-19 preventive measures). The Authors could also include a figure in order to illustrate their hypotheses regarding DRSD. I could help in making the manuscript easier to follow. #2. The abstract includes the sentences which are the copies of sentences present within the manuscript. I suggest to correct it in order to avoid repetitions. #3. Throughout the manuscript the Authors are using wording suggesting causal role of the DRSD for political attitudes (e.g., p. 2; l. 29; p. 16; l. 344-346). Their studies are cross-sectional and correlational. Such a design gives no argument for causal interpretations. #4. The first paragraphs of the introduction should be concise and avoid unnecessary references. I think that the Authors could simply introduce the DRSD and illustrate the beliefs similar to DRSR during the pandemic with one example. I am also wondering whether personal references to politicians are necessary. #5. The suggestions that the DRSD beliefs “have been formed or changed during the pandemic” could be premature. The statements that arose during the pandemic and seem to be the examples of the DRSD could be better see globally, but could be previously present e.g. in individual’s attitudes toward the health care systems in their countries. The sentences such as “although social Darwinism has been widespread in societies for a long time, it can be assumed that the COVID-19 pandemic has increased the prevalence of this thinking” better express the possible situation associated with the DRSD beliefs. #6. Study 1 has numerous goals. Moreover, the Authors stated: “Most importantly, however, we want to show that the scale has incremental validity in comparison to the standard social Darwinism scale when predicting people’s protective behavior during the COVID-19 pandemic (Hypothesis 3a)”. In my opinion, the central goal of the study 1 was to develop the measure of the DRSD. Thus, inspection of its internal structure and validity should be the main goal of the Study 1. #7. The better justifications of sample size in both studies are necessary. The sentences such as “We decided to recruit around 300 participants based on Rudman and Saud (2020), who recruited around 400 participants for most of their studies but also computed more complex calculations than we planned for” are not enough. How the number of the participant could be described in the context of the measure development? Or in the context of stability of correlation coefficients? #8. Better descriptions of exclusion and inclusion criteria are missing in both studies. #9. Did the Authors use also the parallel analysis in order to inspect the correct number of factors in the DRSD measure? #10. According to the Authors hypothesis that the DRSD is a variant of SD, the hypotheses about associations between the DRSD, SDO, and RWA, should be tested by using partial correlation (controlled for SD). SDO and SD are correlated stronger that the DRSD and SDO. The Authors should also mention such results in the discussion. In my opinion some CFA testing whether the DRSD and SD are different construct could be useful. #11. The justification of using separate RAs to examine the associations between party preferences and left/right political orientation should be provided in the manuscript. Which were the correlations between these variables? In general, the authors can provide statistics concerning collinearity in their RA analysis. #12. The Authors used probably a hierarchical regression (see l. 312). Did they centered variables before calculating interactions? Were interactions entered into regression models in separate step? Did that step introduce a significant change in R square? How were the interactions unpacked? #13. The description of the goals of Study 2 introduces new construct which were not previously mentioned in the introduction (needs deprivation). I suggest to elaborate on these predictions in separate section in the introduction. In both studies some moderations appeared as a goals of the examinations. However, they were not elaborated and introduce properly in the introduction. Such a situation create a sense of chaotic argumentation and multiple goals which the Authors try to obtained using the one sample. #14. The political orientation measure used in Study 2 should be better described. It consists of 4 Democrats and 4 Republicans, but the calculation is based only on 2 of each category. Please, justify this score calculation. Please also include some data on the validity. #15. The other instruments again create a feeling that the Authors include many measures in their study and tried to find some significant associations with the DRSD. It would be better to clearly justify why these instruments were used. I am wondering why the Authors did not controlled for SD in the study 2? Moreover, the study 2 is less associated with the exact wording of the title, which suggest testing the DRSD in the context of the pandemic. Study 2 is more about the associations between the DRSD and political preferences. #16. The CFA brought inconsistent results. Both CFI and TLI seem proper (but please provide also criteria of fit which were used), but RMSEA is clearly problematic. Moreover, the Authors mention two-factor solution, which was not previously described. Did the Authors tested the differences between chi square of both one- and two-factor solutions? #17. The hierarchical RA in Study 2 looks problematic. First, when the goals is to analyze interaction, the Authors have to state how they computed interaction term, and did he model explained more variance when the interaction term was entered. Some standardized betas are higher than 1.00 – please explain such situation. Again, collinearity statistics are necessary. #18. The sections entitled “Is social Darwinism an individual, intergroup, or societal phenomenon?” seem misleading in the discussion. The studies were about the DRSD, not the SD itself. Thus, I suggest to keep to the results of the Authors’ studies. However, the structure of this section could be used to structure the introduction in terms of correlates of the DRSD. Reviewer #2: I would like to thank for possibility to review this paper on subject of creation of disease-specific social Darwinism scale. Even general social Darwinism is a rather narrow variable, disease-specific social Darwinism very much so. I think that constructing such a measurement tool, very specific in scope, brings limited novelty to the literature. In my opinion, such a niche scale should be of utmost quality in order to be consider worthy of publication. Theoretical part of the article is well-written and concise; the same could be said about discussion. Scale has good reliability. Method chosen for testing scale’s validity are proper, but Authors do not test validity by any other way than other questionnaires, which is unfortunate. The same applies to predicting behavior during pandemic “over and above” general social Darwinism. It is great idea, but unfortunately behavior was measured by 2 simple, self-report questions. In my opinion, authors should implement at least one non-self-report measure to check scale’s validity. It is harder to do, but if scales are validated only by other paper-and-pencil measures, we cannot be fully sure what is their relation to real world. In summary, I think this article is just not giving enough: in case of small, narrow contribution, it should met the highest standards. I would recommend publishing this article only if authors provide non-paper-and-pencil proves of scale validity and predictive utility (which may require additional study). I also have two minor comments: 1. I couldn’t find information about national identity of the participants of the first study; Authors inform in the abstract that they collected data from two nationalities, but it is not evident what is the first one 2. Beta’s should not be written in italics ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Marcin Moroń Reviewer #2: Yes: Jarosław Piotrowski ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-19515R1Survival of the Fittest in the Pandemic Age: Introducing Disease-Related Social DarwinismPLOS ONE Dear Dr. Nachtwey, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 26 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Peter Karl Jonason Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The revised version of the manuscript was substantially improved. The Authors put a great effort in the revision and adressed all suggestions of the reviewers. I have now only a few suggestions: #1. There are some possible problems with collinearity presented in Table 4 (DV: protective behavior; IV: Left/Right; DRSD; Interaction). Similar situation is present in Table 7 (see a lot of Tolerance is below .100). I think that the Authors should at least comment on this possible problem and, preferably, explain it. #2. Given the study model which indicates that DRSD is a part/form of social darwinism, I think that the Authors could indicate how these two phenomenons are structurally separate. I think that for the clarity, additional EFA on the items of both DRSD and SD could be beneficial. In example, the Authors could include this analysis only as a note. #3. In Study 1 and Study 2, e.g. a Harman's test for detection of common method bias could be an additional information in favor of the Authors standing that the tested variables were indeed independent and the validity analysis was conducted properly. Reviewer #2: I would like to congratulate Author(s) on the good work done. In my opinion, manuscript is much better now and deserves for publication as is. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Marcin Moroń Reviewer #2: Yes: Jarosław Piotrowski ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Survival of the Fittest in the Pandemic Age: Introducing Disease-Related Social Darwinism PONE-D-22-19515R2 Dear Dr. Nachtwey, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Peter Karl Jonason Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-19515R2 Survival of the Fittest in the Pandemic Age: Introducing Disease-Related Social Darwinism Dear Dr. Nachtwey: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Peter Karl Jonason Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .